{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:32:26Z","timestamp":1788492746278,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":171,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pnpbp.2021.110352","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T11:42:23Z","timestamp":1621251743000},"page":"110352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum"],"prefix":"10.1016","volume":"111","author":[{"given":"Jo\u00e3o F.C.","family":"Pedrazzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e2mia R.L.","family":"Joca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.S.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Del Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.b.30140","article-title":"Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report","volume":"134B","author":"Abdolmaleky","year":"2005","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatric Genet. Off. Public. Int. Soc. Psychiatric Genet."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2021.110352_bb0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2011.04.007","article-title":"Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder","volume":"129","author":"Abdolmaleky","year":"2011","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2021.110352_bb0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.schres.2013.12.007","article-title":"DNA hypermethylation of serotonin transporter gene promoter in drug naive patients with schizophrenia","volume":"152","author":"Abdolmaleky","year":"2014","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.pnpbp.2021.110352_bb0025","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/mp.2012.37","article-title":"Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction","volume":"17","author":"Ayalew","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110352_bb0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"1607","key":"10.1016\/j.pnpbp.2021.110352_bb0035","first-page":"3364","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/2045125319881916","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"9","author":"Davies","year":"2019","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0306-4522(02)00415-3","article-title":"Distinct pattern of c-fos mRNA expression after systemic and intra-accumbens amphetamine and MK-801","volume":"115","author":"De Leonibus","year":"2002","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110352_bb0050","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"36","key":"10.1016\/j.pnpbp.2021.110352_bb0055","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1073\/pnas.0805493105","article-title":"Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation","volume":"105","author":"Dong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110352_bb0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopsych.2014.08.012","article-title":"Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice","volume":"77","author":"Dong","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2021.110352_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2014.10.030","article-title":"DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients","volume":"167","author":"Dong","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.191","article-title":"Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs","volume":"6","author":"Dong","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/mol.118.113415","article-title":"N-Phthalyl-l-tryptophan (RG108), like clozapine (CLO), induces chromatin remodeling in brains of prenatally stressed mice","volume":"95","author":"Dong","year":"2019","journal-title":"Mol. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2021.110352_bb0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.schres.2016.02.012","article-title":"A network of synaptic genes associated with schizophrenia and bipolar disorder","volume":"172","author":"Forero","year":"2016","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.pnpbp.2021.110352_bb0085","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/nn.4399","article-title":"Gene expression elucidates functional impact of polygenic risk for schizophrenia","volume":"19","author":"Fromer","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2021.110352_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu041","article-title":"Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice","volume":"18","author":"Gomes","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.009","article-title":"Repeated methamphetamine and modafinil induce differential cognitive effects and specific histone acetylation and DNA methylation profiles in the mouse medial prefrontal cortex","volume":"82","author":"Gonzalez","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/npp.2012.125","article-title":"The dynamics of DNA methylation in schizophrenia and related psychiatric disorders","volume":"38","author":"Grayson","year":"2013","journal-title":"Neuropsychopharmacol.: Off. Public. Am. College Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/WNR.0b013e32800fefd7","article-title":"S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis","volume":"18","author":"Guidotti","year":"2007","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopsych.2014.07.011","article-title":"Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity","volume":"77","author":"Hall","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110352_bb0115","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of Cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherap. J. Am. Soc. Exp. NeuroTherapeutics"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2021.110352_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbr.2009.08.003","article-title":"Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice","volume":"205","author":"Issy","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110352_bb0130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00213-013-3277-4","article-title":"Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice","volume":"231","author":"Issy","year":"2014","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/mp.2014.7","article-title":"Long-term parental methamphetamine exposure of mice influences behavior and hippocampal DNA methylation of the offspring","volume":"20","author":"Itzhak","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110352_bb0140","first-page":"107704","article-title":"Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology","author":"Kaar","year":"2019","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110352_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030632","article-title":"Effect of clozapine on DNA methylation in peripheral leukocytes from patients with treatment-resistant schizophrenia","volume":"18","author":"Kinoshita","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-0082(98)00098-7","article-title":"The neurobiology of startle","volume":"59","author":"Koch","year":"1999","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110352_bb0155","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s12035-019-01831-2","article-title":"Cannabidiol improves cognitive impairment and reverses cortical transcriptional changes induced by ketamine, in schizophrenia-like model in rats","volume":"57","author":"Kozela","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/mp.2009.117","article-title":"Identification of blood biomarkers for psychosis using convergent functional genomics","volume":"16","author":"Kurian","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"20","key":"10.1016\/j.pnpbp.2021.110352_bb0165","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110352_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5607\/en.2015.24.3.177","article-title":"Roles of mTOR signaling in brain development","volume":"24","author":"Lee","year":"2015","journal-title":"Exp. Neurobiol."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.b.30481","article-title":"Towards understanding the schizophrenia code: an expanded convergent functional genomics approach","volume":"144B","author":"Le-Niculescu","year":"2007","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatric Genet. Off. Public. Int. Soc. Psychiatric Genet."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110352_bb0185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40263-018-0539-z","article-title":"Role of the Endocannabinoid system in the pathophysiology of schizophrenia: implications for pharmacological intervention","volume":"32","author":"Leweke","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2021.110352_bb0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2021.110352_bb0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fgene.2018.00343","article-title":"A perspective of the cross-tissue interplay of genetics, epigenetics, and transcriptomics, and their relation to brain based phenotypes in schizophrenia","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.pmbts.2018.01.006","article-title":"DNA methylation and psychiatric disorders","volume":"157","author":"Liu","year":"2018","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110352_bb0205","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.npp.1300838","article-title":"Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice","volume":"31","author":"Long","year":"2006","journal-title":"Neuropsychopharmacol. Off. Public. Am. College Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0210","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for Cannabidiol in cannabinoid CB2 receptors","volume":"8","author":"Martinez-Pinilla","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0215","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neuropharm.2012.04.013","article-title":"Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice","volume":"68","author":"Matrisciano","year":"2013","journal-title":"Neuropharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2021.110352_bb0220","article-title":"The epigenetic mechanisms of amphetamine","volume":"2015","author":"McCowan","year":"2015","journal-title":"J. Addict. Prevent."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110352_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.pnpbp.2021.110352_bb0230","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0040-4020(63)85022-X","article-title":"Hashish I. The structure of cannabidiol","volume":"19","author":"Mechoulam","year":"1963","journal-title":"Tetrahedron"},{"issue":"6","key":"10.1016\/j.pnpbp.2021.110352_bb0235","first-page":"2712","article-title":"Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset","volume":"26","author":"Melas","year":"2012","journal-title":"FASEB J. Off. Public. Feder. Am. Soc. Exp. Biol."},{"issue":"Suppl. 3","key":"10.1016\/j.pnpbp.2021.110352_bb0240","first-page":"3","article-title":"Outcome in schizophrenia: beyond symptom reduction","volume":"60","author":"Meltzer","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110352_bb0245","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2008.01.008","article-title":"Epigenomic profiling reveals DNA-methylation changes associated with major psychosis","volume":"82","author":"Mill","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.pnpbp.2021.110352_bb0250","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacol. Off. Public. Am. College Neuropsychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2021.110352_bb0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.nlm.2016.08.012","article-title":"Impact of DNMT1 and DNMT3a forebrain knockout on depressive- and anxiety like behavior in mice","volume":"135","author":"Morris","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0280","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bbr.2013.09.006","article-title":"Persistent gene expression changes in NAc, mPFC, and OFC associated with previous nicotine or amphetamine exposure","volume":"256","author":"Mychasiuk","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1523\/JNEUROSCI.3796-07.2008","article-title":"Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation","volume":"28","author":"Nelson","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/jhg.2012.140","article-title":"Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia","volume":"58","author":"Nishioka","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0295","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neubiorev.2016.11.012","article-title":"A systematic review of the effect of cannabidiol on cognitive function: relevance to schizophrenia","volume":"72","author":"Osborne","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0300","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pnpbp.2017.10.004","article-title":"DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions","volume":"81","author":"Ovenden","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110352_bb0305","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1074\/jbc.M707964200","article-title":"Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner","volume":"283","author":"Paradisi","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0310","first-page":"7","article-title":"Neurotrophin regulation of neural circuit development and function. Nature reviews","volume":"14","author":"Park","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2021.110352_bb0315","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0083-6729(09)81017-0","article-title":"Regulation of gene transcription and keratinocyte differentiation by anandamide","volume":"81","author":"Pasquariello","year":"2009","journal-title":"Vitam. Horm."},{"issue":"16","key":"10.1016\/j.pnpbp.2021.110352_bb0320","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00213-015-3945-7","article-title":"Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine","volume":"232","author":"Pedrazzi","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2021.110352_bb0325","first-page":"100146","article-title":"The role of genetics in cognitive remediation in schizophrenia: a systematic review. Schizophrenia research","volume":"19","author":"Penades","year":"2020","journal-title":"Cognition"},{"key":"10.1016\/j.pnpbp.2021.110352_bb0330","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-319-53889-1_12","article-title":"DNA methylation in schizophrenia","volume":"978","author":"Pries","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.pnpbp.2021.110352_bb0335","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/bph.12309","article-title":"Epigenetic control of skin differentiation genes by phytocannabinoids","volume":"170","author":"Pucci","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0340","doi-asserted-by":"crossref","first-page":"104749","DOI":"10.1016\/j.phrs.2020.104749","article-title":"Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors","volume":"156","author":"Rodrigues da Silva","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.pnpbp.2021.110352_bb0345","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0350","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pnpbp.2018.06.002","article-title":"Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels","volume":"86","author":"Sales","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0355","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0360","doi-asserted-by":"crossref","first-page":"112627","DOI":"10.1016\/j.bbr.2020.112627","article-title":"CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim","volume":"388","author":"Sales","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0365","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.pnpbp.2021.110352_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.143","article-title":"Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients","volume":"7","author":"Shi","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110352_bb0375","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/bs.pmbts.2018.04.009","article-title":"Methodologies of Neuroepigenetic research: background, challenges and future perspectives","volume":"158","author":"Snijders","year":"2018","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0380","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbr.2016.04.042","article-title":"Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice","volume":"309","author":"Sonego","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110352_bb0385","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2018.11.035","article-title":"Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia","volume":"146","author":"Stark","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0390","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0006-3223(86)90005-3","article-title":"Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics","volume":"21","author":"Swerdlow","year":"1986","journal-title":"Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2021.110352_bb0395","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-8993(90)91754-5","article-title":"GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats","volume":"532","author":"Swerdlow","year":"1990","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0400","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/026988119200600210","article-title":"The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications","volume":"6","author":"Swerdlow","year":"1992","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0405","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","article-title":"Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients","volume":"51","author":"Swerdlow","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2021.110352_bb0410","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110352_bb0415","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1017\/S1461145713001442","article-title":"Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia","volume":"17","author":"Tang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0420","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-3565(24)37365-3","article-title":"Comparative receptor binding analyses of cannabinoid agonists and antagonists","volume":"285","author":"Thomas","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2021.110352_bb0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0091-3057(94)90470-7","article-title":"Accumbens D2 modulation of sensorimotor gating in rats: assessing anatomical localization","volume":"49","author":"Wan","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"8","key":"10.1016\/j.pnpbp.2021.110352_bb0430","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1248\/bpb.19.1109","article-title":"Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids","volume":"19","author":"Watanabe","year":"1996","journal-title":"Biol. Pharm. Bull."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2021.110352_bb0435","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002130100800","article-title":"Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review","volume":"156","author":"Weiss","year":"2001","journal-title":"Psychopharmacology"},{"issue":"32","key":"10.1016\/j.pnpbp.2021.110352_bb0440","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.2174\/138161212802884744","article-title":"The endocannabinoid system and schizophrenia: integration of evidence","volume":"18","author":"Zamberletti","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002130000369","article-title":"Role of dopamine in prepulse inhibition of acoustic startle","volume":"149","author":"Zhang","year":"2000","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2021.110352_bb0450","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bbrc.2018.12.058","article-title":"The effect of glutamate-induced excitotoxicity on DNA methylation in astrocytes in a new in vitro neuron-astrocyte-endothelium co-culture system","volume":"508","author":"Zhao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.pnpbp.2021.110352_bb0455","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.pnpbp.2021.110352_bb0460","first-page":"485","article-title":"Antipsychotic effect of cannabidiol","volume":"56","author":"Zuardi","year":"1995","journal-title":"J. Clin. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:58:12Z","timestamp":1759521492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":91,"alternative-id":["S0278584621001111"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110352","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110352"}}